Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05033067 · ClinicalTrials.gov registry record · NA
The Personal Patient Profile Decision Support for Patients With Bladder Cancer
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT05033067 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 24 participants.
The verdict
NCT05033067, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
There is a pressing need to develop a personalized, value-based decisional tool for bladder cancer patients undergoing radical cystectomy (bladder removal) and urinary diversion to help them with communication with the physicians, shared decision making, and preparation for disease-management and follow-up care. The proposed intervention, the Personal Patient Profile - Bladder Cancer (P3-BC), will be the first intervention to address these issues. Results of this pilot randomized feasibility study will provide evidence of the feasibility and acceptability of the P3-BC and will guide further refinement of the tool for a larger experimental trial, with potential dissemination of the program via the Internet and hand-held computing devices.
Interventions
- BEHAVIORAL P3BC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-06-10 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05033067
The ClinicalTrials.gov registry entry for NCT05033067 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which P3BC is the first listed.
NCT05033067 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05033067 about?
NCT05033067 is a clinical study titled "The Personal Patient Profile Decision Support for Patients With Bladder Cancer". There is a pressing need to develop a personalized, value-based decisional tool for bladder cancer patients undergoing radical cystectomy (bladder removal) and urinary diversion to help them with communication with the physicians, shared decision making, and preparation for disease-management and fo...
What is the current status of trial NCT05033067?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-06-10. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT05033067?
The interventions under investigation include: P3BC (BEHAVIORAL).
Who is sponsoring clinical trial NCT05033067?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.